Peptides

1213 from 1278 pages
No results were found for the filter!
beta-Endorphin (1-27) (human)
beta-Endorphin (1-27) (human)

Item number: TGM-T80515-50mg

Description: beta-Endorphin (1-27) (human) is an opioid antagonist that selectively binds to µ-, delta-, and kappa-opioid receptors, with dissociation constants (Kis) of 5.31, 6.17, and 39.82 nM, respectively. It inhibits analgesia induced by both beta-Endorphin and etorphine [1][2]. Target: Opioid Receptor
CAS 76622-84-9
MW: 3022.47 D
Please request pricing for this article.
Review
human GALP (3-32)
human GALP (3-32)

Item number: TGM-T80516-50mg

Description: Human GALP (3-32) (Galanin-like peptide (3-32)) serves as a high-affinity agonist for galanin receptors GalR1 (IC50 = 33 nM) and GalR2 (IC50 = 15 nM), as evidenced by competitive binding studies. It demonstrates significant potency in modifying the extracellular acidification rate in SH-SY5Y cells...
Keywords: Galanin-like peptide (3-32)
MW: 3102.49 D
Please request pricing for this article.
Review
Ala5-Galanin (2-11)
Ala5-Galanin (2-11)

Item number: TGM-T80517-50mg

Description: Ala5-Galanin (2-11) is a specific agonist for the galanin receptor 2 (GAL2R) with an affinity constant (Ki) of 258 nM [1]. Target: Neuropeptide Y Receptor
CAS 859843-84-8
MW: 1120.3 D
Please request pricing for this article.
Review
Mambalgin-3
Mambalgin-3

Item number: TGM-T80518-50mg

Description: Mambalgin-3, an acid-sensitive ion channel 1 (ASIC1) inhibitor, has potential applications in analgesia research [1]. Target: Sodium Channel
MW: 6566.54 D
Please request pricing for this article.
Review
m3-Huwentoxin IV
m3-Huwentoxin IV

Item number: TGM-T80519-50mg

Description: m3-Huwentoxin IV (m3-HwTx-IV) is a potent inhibitor of sodium channels (NaV), with half-maximal inhibitory concentrations (IC50s) of 3.3 nM for hNaV1.7, 6.8 nM for hNaV1.6, 7.2 nM for hNaV1.3, 8.4 nM for hNaV1.1, 11.9 nM for hNaV1.2, and 369 nM for hNaV1.4 in the QPatch assay. It also alleviates...
Keywords: m3-HwTx-IV
MW: 3985.69 D
Please request pricing for this article.
Review
omega-conotoxin MoVIA
omega-conotoxin MoVIA

Item number: TGM-T80520-50mg

Description: omega-Conotoxin MVIIA is a potent, selective inhibitor of Ca_v2.2, exhibiting an IC_50 of 0.33 µM in the SH-SY5Y fluorimetric hCa_v2.2 assay [1]. Target: Calcium Channel
MW: 3607.15 D
Please request pricing for this article.
Review
Caveolin-1 (82-101) amide (human, mouse, rat)
Caveolin-1 (82-101) amide (human, mouse, rat)

Item number: TGM-T80521-50mg

Description: Caveolin-1 (82-101) amide (human, mouse, rat), also known as Caveolin-1 scaffolding domain peptide, mitigates aging-related detrimental alterations in various organs and inhibits tyrosine kinases [1]. Target: c-Met/HGFR
Keywords: Caveolin-1 scaffolding domain peptide
CAS 2757108-69-1
MW: 2516.85 D
Please request pricing for this article.
Review
Azurin p28 peptide
Azurin p28 peptide

Item number: TGM-T80523-50mg

Description: Azurin p28 peptide, a tumor-penetrating antitumor agent, stabilizes p53 by reducing its proteasomal degradation via the formation of a p28:p53 complex. It elicits apoptosis or cell cycle arrest and suppresses the growth of p53-positive tumors. Additionally, the peptide exhibits antiangiogenic properties...
CAS 897026-25-4
MW: 2914.18 D
Please request pricing for this article.
Review
Vm24-toxin
Vm24-toxin

Item number: TGM-T80524-50mg

Description: Vm24-toxin, a peptide toxin isolated from the Mexican scorpion Vaejovis mexicanus smithi, serves as an inhibitor of the Kv1.3 potassium channel [1]. Target: Potassium Channel
Keywords: Vaejovis mexicanus peptide 24
CAS 1373890-79-9
MW: 3863.59 D
Please request pricing for this article.
Review
E70K
E70K

Item number: TGM-T80525-50mg

Description: E70K, a CXCL8 C-terminal peptide, features a lysine (K) substitution for glutamic acid (E) at position 70 and has demonstrated the ability to attenuate neutrophil adhesion and migration in the context of inflammation [1]. Target: CXCR
MW: 2400.78 D
Please request pricing for this article.
Review
L-K6L9
L-K6L9

Item number: TGM-T80526-50mg

Description: L-K6L9 exhibits antimicrobial and antibiofilm properties effective against P. aeruginosa associated with cystic fibrosis, demonstrating both stability and resistance to degradation by sputum proteases from cystic fibrosis patients, without inducing bacterial resistance [1].
CAS 507238-92-8
MW: 1804.48 D
Please request pricing for this article.
Review
D-K6L9
D-K6L9

Item number: TGM-T80527-50mg

Description: D-K6L9 exhibits antimicrobial and antibiofilm properties effective against Pseudomonas aeruginosa isolated from patients with cystic fibrosis. The compound demonstrates stability and resistance to degradation by proteases found in cystic fibrosis sputum and does not promote bacterial resistance [1].
CAS 426264-61-1
MW: 1804.48 D
Please request pricing for this article.
Review
1213 from 1278 pages